|
Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials |
University of California, San Diego |
Northwestern Mutual Foundation |
|
Next-Generation Personalized Neuroblastoma Therapy (Nepenthe) |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
DNA Sequencing Using Malaria Slides |
Indiana University |
Northwestern Mutual Foundation |
|
Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |
|
Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma |
Dana-Farber Cancer Institute |
Flashes of Hope |
|
Optimizing Bispecific Antibody Therapy for Acute Leukemias |
Fred Hutchinson Cancer Research Center |
Cure4Cam Childhood Cancer Foundation |
|
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb |
University of Wisconsin - Madison |
Northwestern Mutual Foundation |
|
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
|
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
|
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
